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Aims Electroneutral (NBCn1) and electrogenic (NBCe1) isoforms of the Na+–HCO−3 cotransporter (NBC) coexist in the
heart. We studied the expression and function of these isoforms in hearts of Wistar and spontaneously hypertensive
rats (SHR), elucidating the direct implication of the renin–angiotensin system in the NBC regulation.
Methods
and results
We used myocytes from Wistar, SHR, losartan-treated SHR (Los-SHR), and Angiotensin II (Ang II)-induced cardiac
hypertrophy. We found an overexpression of NBCe1 and NBCn1 proteins in SHR that was prevented in Los-SHR.
Hyperkalaemic-induced pHi alkalization was used to study selective activation of NBCe1. Despite the increase in
NBCe1 expression, its activity was lower in SHR than in Wistar or Los-SHR. Similar results were found in Ang II-
induced hypertrophy. A specific inhibitory antibody against NBCe1 allowed the discrimination between NBCe1 and
NBCn1 activity. Whereas in SHR most of the pHi recovery was due to NBCn1 stimulation, in Wistar and Los-SHR
the activity of both isoforms was equitable, suggesting that the deteriorated cardiac NBCe1 function observed in SHR
is compensated by an enhanced activity of NBCn1. Using the biotin method, we observed greater level of internalized
NBCe1 protein in SHR than in the non-hypertophic groups, while with immunofluorescence we localized the protein
in endosomes near the nucleus only in SHR.
Conclusions We conclude that Ang II is responsible for the impairment of the NBCe1 in hypertrophied hearts. This is due to retained
transporter protein units in early endosomes. Moreover, NBCn1 activity seems to be increased in the hypertrophic myo-
cardium of SHR, compensating impaired function of NBCe1.
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1. Introduction
In the heart the main alkalinizing mechanisms which neutralize acid in the
cell are the Na+–H+ antiporter (NHE) and the Na+–HCO−3 cotran-
sporter (NBC), which exports H+ and imports HCO−3 into the cell,
respectively. NBC is responsible for 40–50% of total acid extrusion in
cardiacmyocytes.1 –3 At present, it is knownthat in ventricular myocytes
exist at least two functional isoforms of NBC: the electroneutral
NBCn1, which introduces one molecule of Na+ per molecule of
HCO−3 and the electrogenic NBCe1, which promotes the co-influx of
one molecule of Na+ per two molecules of HCO−3 .
4,5 Both isoforms
regulate intracellular pH (pHi) and intracellular Na
+ concentration
([Na+]i).
6 In addition, NBCe1 generates an anionic current that contri-
butes to the action potential (AP) repolarization.7 –9
In a recent study, using a selective inhibitory antibody against the
extracellular loop 3 of NBCe1 (a-L3), we were able to discriminate
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the relative contribution of NBCe1 and NBCn1 to total NBC activity in
feline ventricular cardiomyocytes during the recovery from acidosis.4 In
this work, we have shown that the activity of both isoforms is equivalent.
Moreover, in the presence of the a-L3 the cardiac action potential
duration (APD) was longer than in its absence, indicating the relevance
of NBCe1 in cardiac electrical properties.4
It was demonstrated that Angiotensin II (Ang II) stimulates total NBC
activity during the recovery from acidosis both in rat and in cat adult ven-
tricular myocytes.3,10 Moreover, we have recently shown a differential
effect of Ang II on NBC isoforms, demonstrating that Ang II inhibits
NBCe1 via p38-kinase activation, whereas activates NBCn1 in an ERK
1/2 and reactive oxygen species (ROS)-dependent mechanism. The
net effect is an up-regulation of NBC activity since the Ang II-induced
stimulation of NBCn1 is only partially masked by the inhibition
of NBCe1.9
The spontaneously hypertensive rats (SHRs) are a well-established
genetic model of hypertension and heart hypertrophy. It was demon-
strated that the cardiac APD of SHR is prolonged in comparison with
that of normotensive animals.11 In addition, the [Na+]i and [Ca
2+]i are
increased in hypertrophied hearts.12– 14 It is also known that the
renin–angiotensin system is involved in the development of hyperten-
sion, cardiac hypertrophy, and subsequent transition to heart failure.
In concordance, the levels of Ang II15–18 and the Ang II receptors
AT1
19 are increased in hypertrophied hearts.
It was proposed that at least part of the maladaptive cardiac mass
growth is caused by an autocrine/paracrine event triggered by myocar-
dial stretch that begins with the activation of AT1 receptors,
20,21 involves
the production of ROS22 and the activation of several kinase pathways.20
One clear target of these intracellular pathways is the NHE, which it has
been shown to be up-regulated in several models of cardiac hyper-
trophy.23– 26 In addition, the NBC was shown to be overexpressed
and hyperactive in aortic constriction-induced cardiac hypertrophy.27
However, the precise implication of NBC in cardiac hypertrophy has
not been well established yet. The aim of the present research was to
investigate the pathophysiological role of the cardiac NBC isoforms in
the SHR in order to bring new insights into their potential implication
in the hypertensive cardiac hypertrophy.
2. Materials
All procedures followed during this investigation conform to the Guide
for the Care and Use of Laboratory Animals published by the US National
Institutes of Health (NIH Publication No. 85–23, revised 1996), and
the experimental protocol was approved by the Animal Welfare Com-
mittee of La Plata School of Medicine. Male rats (body weight 300–
400 g) were anaesthetized by i.p. injection of sodium pentobarbital
(35 mg/kg body weight) and hearts rapidly excised when plane three
of phase III of anaesthesia was reached.
A group of SHR male rats was treated during 1 month with the Ang II
type 1 receptor blocker losartan (40 mg/kg/day; Los-SHR).
2.1 Cell isolation
Ventricular myocytes were isolated according to the technique previ-
ously described,28 using 6-month-old Wistar, SHR, and Los-SHR.
2.2 pHi measurements
pHi was measured in single myocytes with an epi-fluorescence system
(Ion Optix, Milton, MA, USA) using the previously described BCECF
technique.9 The intrinsic buffering capacity (bi; see Supplementary
material online) was significantly higher in cardiac myocytes from
Wistar than in cardiomyocytes from SHR (at pHi of 6.9: 56.02+
0.10 mM/pH units, n ¼ 14 vs. 34.12+0.09 mM/pH units, n ¼ 12; P,
0.05). This depressed bi of the SHR cardiomyocytes was not reversed
by the treatment with losartan (at pHi of 6.9: 33.91+0.06 mM/pH
units, n ¼ 6).
2.3 Immunodetection
NBCe1andNBCn1expressionweredeterminedbywesternblots (W-B)
with specific antibodies as previously described.4 In addition, the biotin
method was employed to determine the fraction of NBCe1 expressed
in the sarcolemma.29
2.4 Immunostaining of cardiac myocytes
and analysis by confocal microscopy
Fresh single dissociated rat ventricular myocytes were plated onto 22 ×
22-mm laminin (30 mg/mL)-coated glass coverslips and incubated with
specific antibodies, as previously described.4
2.5 Rats treated with Ang II
Male Wistar rats, weighing 300–400 g, were anaesthetized by inhalation
of 2% sevoflurane, 98% oxygen, and an osmotic minipump (Alzet 2004)
for s.c. of Ang II (200 mg/kg/day; Sigma) was implanted under the skin.
The control animals were also anaesthetized in order to simulate the
surgery. Blood pressure (BP) monitored by tail cuff plethysmography
and echocardiographic parameters was recorded before and after treat-
ment. On Day 30 after implantation of minipumps, animals were
sacrificed and the hearts were isolated to perform the functional and
molecular experiments.
2.6 Statistics
Data were expressed as means+ SEM and were compared with
Student’s t-test or one-way ANOVA followed by the Student–
Newman–Keuls post hoc test. A value of P, 0.05 was considered
statistically significant (two-tailed test).
An expanded Methods section is available in Supplementary material
online.
3. Results
3.1 Cardiac hypertrophy parameters
The systolic BP measured by the plethysmographic method and the
hypertrophy indexes determined by echocardiography in Wistar,
SHR, and Los-SHR are shown in Table 1. As expected, the hypertension
and cardiac hypertrophy of SHR were partially reversed by the treat-
ment with losartan.
3.2 Potassium pulses: the activity of NBCe1
is impaired in SHR
Wistar and SHR myocytes were exposed to a high extracellular K+
solution. This hyperkalaemic solution induced a depolarization of the
membrane potential which selectively stimulated NBCe1 and therefore
resulted in cellular alkalization. The HCO−3 influx (JHCO−3 )obtained from
the initial velocity of increase in pHi and the total intracellular buffering
capacity was compared (see Supplementary material online). Figure 1A
shows representative traces of continuous pHi recordings in Wistar,
SHR, and Los-SHR. As observed in the average results (Figure 1B), the
JHCO−3 was significantly smaller in SHR myocytes in comparison with
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their Wistar controls. In addition, the myocytes derived from Los-SHR
presented an NBCe1 activity intermediate between that of the Wistar
and SHR. These results indicate that the NBCe1 activity is impaired
in SHR, and that this behaviour is partially prevented when the AT1
receptors were blocked with losartan.
3.3 Ammonium pulses: NBCn1
overexpression compensates
NBCe1-impaired activity in SHR
The total NBC (NBCe1 + NBCn1) activity was assessed by evaluating
the pHi recovery from an ammonium pre-pulse-induced acute acid
load in a medium containing bicarbonate and in the continuous presence
of HOE 642 10 mM (NHE blocker). Serum containing the inhibitory anti-
body against the extracellular loop 3 of the NBCe1 (a-L3)4 was used to
differentiate the relative participation of both isoforms during the recov-
ery from the acidosis; NBCn1 activity was estimated as the pHi recovery
in the presence of a-L3, whereas NBCe1 activity was calculated as the
control pHi recovery (total NBC) minus the NBCn1 activity. Non-
immune serum was used as a control.4 The selective inhibitory effect
of a-L3 on the function of the NBCe1 expressed in the rat cardiomyo-
cytes is shown in Supplementary material online, Figure S1. Figure 2A illus-
trates superimposed traces of Wistar, SHR, and Los-SHR myocytes in
the presence and absence of a-L3 (dilution 1/500). Figure 2B compares
the JHCO−3 calculated at pHi of 6.9 in the three different conditions.
Total JHCO−3 (NBCe1 + NBCn1) was smaller in SHR than in Wistar or
Los-SHR, although this difference did not attain a statistical significance.
More interestingly, whereas the Wistar myocytes showed an equivalent
NBCn1 and NBCe1 activity, the SHR myocytes exhibited almost exclu-
sive NBCn1 activity. Importantly, the Los-SHR recovered the equitable
Figure1 NBCe1 activity determined by the potassium pulse: (A) Representative traces of pHi recorded from ventricular myocytes isolated from Wistar,
SHR, and Los-SHR during exposure to the potassium pulse. The slope (grey line), corresponding to the initial velocity during the alkalinization produced by
the potassium pulse, was used to determined HCO−3 influx. The vertical dotted lines indicate the points on the fit curves at which these slopes were deter-
mined. (B) Average data of the JHCO−3 obtained from the initial velocity of the pHi alkalinization induced by the hyperkalaemic-induced depolarization of
membrane potential in myocytes from Wistar (n ¼ 23 myocytes from 11 rats), SHR (n ¼ 25 myocytes from 9 rats), and Los-SHR (n ¼ 23 myocytes
from 7 rats). *P, 0.05 vs. Wistar and Los-SHR. &P, 0.05 vs. Wistar.
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Table 1 General characteristics of Wistar, SHR, and Los-SHR rats
Wistar SHR Los-SHR
BP 118.4+2.3 (n ¼ 15) 198.5+4.7 (n ¼ 15)* 140.7+1.6 (n ¼ 11)#
BW 325.4+9.2 (n ¼ 15) 341.8+9.5 (n ¼ 15) 328.8+7.3 (n ¼ 15)
LVM 456+28.9 (n ¼ 15) 695.5+19.01 (n ¼ 15)* 516.5+13.32 (n ¼ 15)
LVMI 1.41+0.09 (n ¼ 15) 2.04+0.06 (n ¼ 15)* 1.57+0.03 (n ¼ 15)
BP, blood pressure (mmHg); BW, body weight (g); LVM, left ventricular mass (mg); LVMI, left ventricular mass index, calculated as the ratio LVM/BW (mg/g).
*P, 0.05 vs. Wistar and Los-SHR.
#P, 0.05 vs. Wistar.
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participationofNBC isoforms, similar to theoneexhibitedby the Wistar
myocytes (Figure 2B). In concordance with these functional results, W-B
analysis demonstrated that, compared with Wistar hearts, NBCn1
expression in SHR was significantly higher (Figure 2C). Furthermore,
the treatment with losartan abrogated the up-regulation of NBCn1 in
SHR hearts (Figure 2C). These data indicate that in SHR, the
NBCe1-impaired activity might be compensated by an Ang II-induced
NBCn1 up-regulation.
3.4 Distribution of NBCe1 protein in SHR
Parallel experiments were performed to investigate the NBCe1 expres-
sion. Opposite to it was expected, the NBCe1 expression in SHR hearts
was higher than in Wistar. In addition, the treatment with losartan
prevented this increase (Figure 3).
Previous studies had shown that Ang II induces internalization of
NBCe1 from the plasma membrane in Xenopus laevis oocytes.30 To in-
vestigate whether this phenomenon is taking place in SHR myocytes,
confocal images were taken in both Wistar and SHR myocytes and the
biotinylation technique followed by W-B analysis was used to determine
the level of NBCe1 surface expression. We found that in both strains
NBCe1 was expressed along the sarcolemmal membrane and T
tubules, but interestingly, in SHR myocytes an important fraction of
NBCe1 was retained near the nucleus, possibly in the endoplasmic
reticulum, suggesting a disturbance in NBCe1 trafficking (Figure 4A).
Consistently with an involvement of Ang II in this phenomenon, the
treatment of SHR with losartan reversed this localization pattern
(Figure 4A). The overlay of the NBCe1 signal with an endosome
marker (transferrin receptor; Tfr) was evaluated to quantify the pres-
ence of NBCe1 in endosomes near the nucleus. The signal for NBCe1
Figure 2 Total NBC activity determined by the ammonium pulse. (A) Superimposed representative recordings of pHi obtained from myocytes isolated
from Wistar, SHR, and Los-SHR exposed to an ammonium pulse in the absence (N-I serum representing control) or presence of the serum containing the
functional inhibitory antibody against NBCe1 (a-L3; 1:500). The experiments were performed in the continuous presence of HOE642 (10 mM) in order to
block NHE-1 activity. During these experiments, cells are exposed to external solution containing NH4Cl. External NH3 enters the cell far more rapidly
than external NH4
+ thereby alkalinizing the cell. This alkalinization will continue until the internal and external concentration of NH3 are the same. Upon
removal of external NH4Cl, all the original NH4
+ formed upon exposure will dissociate and regenerate NH3 (which diffuses from the cell) and H
+. In this
point the cell will reach the most acid pHi and will begin the recovering due to the activation of NBC. The slope (grey line), corresponding to the velocity
corresponding to pHi 6.9 during the recovery from acidosis, was used to determined HCO
−
3 influx. The horizontal dotted lines indicate pHi 6.9, which are
the points on the fit curves at which these slopes were determined. (B) JHCO−3 calculated at pHi 6.9 in the absence or presence of a-L3 in Wistar (n ¼ 10
myocytes from 5 rats), SHR (n ¼ 10 myocytes from 6 rats), or Los-SHR (n ¼ 6 myocytes from 4 rats). NBCn1 activity was estimated as the pHi recovery in
the presence of a-L3, whereas NBCe1 activity was calculated as the control pHi recovery (total NBC) minus the NBCn1 activity. Non-immune serum was
used as a control. *P, 0.05 vs. NBCn1. (C) Percentage average expression of NBCn1 (normalized by GAPDH expression) obtained from lysates of ven-
tricles from Wistar (n ¼ 11), SHR (n ¼ 5), or Los-SHR (n ¼ 4). The expression of NBCn1 in Wistar was taken as 100%. *P, 0.05 vs. Wistar and Los-SHR.
A representative blot is shown at the top.
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and Tfr was line-scanned on the same area of the nucleus in each cell
examined. Figure 4B shows the representative traces for such line-
scannings of the cells corresponding to Figure 4A. As the figure shows,
the nucleus exhibited no signal, whereas signals for NBCe1 and Tfr
can be observed in the adjacent areas. In myocytes from Wistar and
Los-SHR, the signals for NBCe1 are low and do not merge with the
signal for Tfr. In contrast, in the myocytes from SHR, the signals for
NBCe1 and Tfr clearly overlay, indicating the presence of NBCe1 in
early endosomes. Figure 4C shows average fluorescence detected in
the nucleus adjacent area for the NBCe1 and Tfr signals. The average
fluorescence values of the NBCe1 and Tfr signals were significantly dif-
ferent in the myocytes from Wistar and Los-SHR and not different in
those from SHR, supporting the existence of an alteration of NBCe1
trafficking in the hypertensive rats.
In concordance with this, the percentage of NBCe1 internalization
was significantly higher in SHR myocytes in comparison with Wistar
(Figure 4D). In addition, the treatment with losartan prevented this phe-
nomenon (Figure 4D). These results suggest that the reduction in NBCe1
activity was secondary to a decrease in its sarcolemmal expression, likely
due to Ang II-induced alteration of NBCe1 trafficking to the plasma
membrane.
A relevant functional consequence of the altered NBCe1 sarcolem-
mal expression in the cardiomyocytes of SHR would be a reduced
impact of this electrogenic transporter on the AP configuration. To
evaluate this hypothesis, we recorded APs with the patch-clamp tech-
nique. As previously reported,11 the APD was significantly longer in
the SHR cardiomyocytes than in those from the normotensive animals
(Figure 5A and B). Figure 5B and C shows the effect of a-L3 on the APD
determined at 90% of repolarization time (APD90). The inhibitory anti-
body was able to significantly prolong the APD in the myocytes of the
Wistar rats (14%, Figure5C), but not in those from the SHR, supporting
the depressed membrane expression of NBCe1 in the latter, as
suggested above.
We finally attempted to further evaluate the involvement of Ang II on
the structural and functional remodelling of NBCe1 by treating Wistar
rats with this hormone (200 mg/kg/day) during 1 month. Ang II
induced a significant percentage increase in BP (23.61+0.07%, n ¼ 7)
and left ventricular mass index (LVMI; 17.64+ 0.02%, n ¼ 7). These
parameters were not affected in the control rats (BP; 0.99+0.02%,
n ¼ 6 and LVMI; 0.94+0.07%, n ¼ 6). Figure 6A shows representative
traces of pHi recorded during the potassium pulse in myocytes isolated
from control- and Ang II-treated rats. As shown in Figure 6B, the average
JHCO−3 obtained from the initial velocity of increase in pHi during the po-
tassium pulse was significantly lower in myocytes from the Ang II-treated
rats than in those from control. These results further support the idea
that the cardiac NBCe1 dysfunction detected in the SHR is induced by
Ang II.
Figure 6C andD depicts the average expression of NBCe1 and NBCn1
in the myocardium from control- and Ang II-treated rats. Similarly to the
observations made for the SHR hearts, the NBCe1 and NBCn1 expres-
sion were increased in the hearts from the Ang II-treated rats. The
depressed cardiac NBCe1 function, despite its enhanced expression,
might reflect the trafficking disturbance of the transporter protein
demonstrated for the SHR myocytes.
4. Discussion
The present work shows that in the SHR exists a remodelling in cardiac
NBC isoforms, which results in a decrease of NBCe1 in the cell surface
and in a compensatory up-regulation of NBCn1. These alterations were
reversed by treatment of the hypertrophic rats with the AT1 antagonist
losartan, suggesting that Ang II is involved in such remodelling. Further-
more, the infusion of Wistar rats with Ang II for 30 days induced cardiac
hypertrophy and mimicked the results on NBC isoforms expression and
NBCe1 function obtained in SHR. These findings allow us to assert that
Ang II is directly involved in the remodelling of NBC isoforms during the
cardiac hypertrophy of SHR rats.
Previous investigationshave demonstrated that Ang II stimulates NBC
activity in rat and cat cardiomyocytes.3,10 Furthermore, we have
reported that Ang II regulates NBC isoforms activity in an opposite
way, activating NBCn1 via ROS and ERK 1/2 kinase stimulation and inhi-
biting NBCe1 in a p38-kinase-dependent manner.9 We found that the
NBCn1 stimulation overrules the NBCe1 inhibition and therefore
resulted in a total NBC stimulation.9 The Ang II-induced NBCe1 inhib-
ition was also demonstrated in renal tubules in a pathway that involves
arachidonic acid.31,32
It is well knownthat Ang II is involved in the pathophysiologyof cardiac
hypertrophy secondary to diverse stimuli. We have previously
suggested that Ang II and endothelin-1 can trigger an intracellular
pathway that stimulates NHE-1 in an ROS and ERK1/2-kinase-depend-
ent manner. This effect increases [Na+]i, activates the reverse mode
of the Na+/Ca2+ (rNCX), enhances the intracellular calcium concentra-
tion ([Ca2+]i), and finally leads to cell growth.
23,24,33 Furthermore, it was
demonstrated that chronic inhibition of NHE-1 prevents or reverses
cardiac hypertrophy.34,35 On the other hand, the overexpression of
the NHE-1 was shown to induce cardiac hypertrophy.36 Based on
these results, it is possible to speculate that a similar intracellular
pathway to the one described above for the NHE-1 might be involved
in the Ang II-induced up-regulation of NBCn1 observed herein in the
hypertrophic hearts. In other words, since it was reported that NBC is
Figure 3 Total NBCe1 expression. Percentage average expression
of NBCe1 (normalized by GAPDH expression) obtained from
lysates of ventricles from Wistar (n ¼ 10), SHR (n ¼ 10), or
Los-SHR (n ¼ 6). The expression of NBCn1 in Wistar was taken as
100%. *P, 0.05 vs. Wistar and Los-SHR. A representative blot is
shown at the top.
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responsible for 30% of Na+ influx into the cells during the recovery from
acidosis,6 the overexpression and up-regulation of NBCn1 in SHR might
be part of the cause of the [Na+]i overload observed in cardiac hyper-
trophy.12– 14 Moreover, taking into account the stoichiometry of both
NBC isoforms, which could lead to the consideration of NBCe1 as a
‘Na+-sparing’ bicarbonate transporter, it is feasible to anticipate that
not only the overexpression of NBCn1, but also the reduction in
NBCe1 function in the hypertrophied hearts would further contribute
to the deleterious effects on [Na+]i and [Ca
2+]i overload.
We have suggested that Ang II-induced NBCe19 inhibition might be
the responsible, at least in part, for the characteristic APD prolongation
induced by this hormone. Herein, we present new data which show that
in SHR myocytes the inhibitoryantibodyagainst NBCe1 (a-L3) exerts no
effect on AP configuration, suggesting that NBCe1 might be already
inhibited due to the up-regulation of the renin–angiotensin system
in SHR.
In the present study, we observed that despite thatbi depends on the
amount of protein in the cell, the larger cardiomyocytes from the SHR
exhibited a 40% lower bi value than that obtained from Wistar rats. It
has been suggested that the increased protein synthesis in hypertrophy
improves intracellular H+ buffering capacity, which might improve the
ability to resist acute acid–base changes.37 However, most of the
studies performed in the myocardium from hypertrophied hearts did
not report a significant increase in the value of bi in comparison with
Figure 4 Localization of NBCe1 in rat ventricular myocytes. (A) Confocal immunofluorescence analysis of the distribution of NBCe1 in rat myocytes
isolated from Wistar, SHR, and Los-SHR. Freshly isolated cardiomyocytes were stained with a combination of rabbit anti-NBCe1 antibody and goat poly-
clonal anti-transferrin receptor antibody (Tfr; marker for endosomal vesicles). Combined primary antibodies were used at 1:100 dilutions. Secondary
chicken anti-rabbit conjugated to Alexa fluor 488 (green) and chicken anti-goat conjugated to Alexa fluor 594 (red) was used at 1:200 dilutions.
Squares represent the area amplified shown in the left. (B) Representative line-scan fluorescence corresponding to Wistar, SHR, and Los-SHR rats,
plotted as the signals for NBCe1 (green) and Trf (red), which were taken in the nucleus and adjacent areas (A; inset, yellow line). (C) Average of
NBCe1 and Trf fluorescence in the nucleus adjacent area (n values are shown between brackets). *P, 0.05 vs. Trf (a.u.). (D) Percentage average expression
of internalized cardiacNBCe1of Wistar (n ¼ 4), SHR (n ¼ 4), and Los-SHR (n ¼ 4) obtained fromthe subtraction of the intracellular expression of NBCe1
(unbound to the sarcolemmal marker biotin) to the total expression of NBCe1 (unbound plus bound to biotin). *P, 0.05 vs. Wistar and Los-SHR. A rep-
resentative blot is shown at the top.
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control.38– 41 Moreover, we showed herein that the treatment with
losartan did not normalize the decreased intrinsic buffer capacity
observed in the hearts of SHR. Thus, it is possible that the cardiac hyper-
trophy is not responsible for the altered intrinsic buffering capacity, but
rather an endogenous property of the strain.
In the last years, the implication of NBC in cardiac pathophysiology
started to be studied. Several studies have demonstrated that cardiac
NBC is activated during ischaemia-reperfusion.42– 44 Moreover, Khan-
doudi et al.45 have demonstrated that selective inhibition of NBCe1
during reperfusion after ischaemia significantly improved contractile re-
covery, indicating that this transporter contributes to the characteristic
intracellular Na+ and Ca2+ overload produced by this pathology. These
authors also showed that NBCe1 is overexpressed in human heart
failure.45 It was also demonstrated that local myocardial infarction
leads to an increase in both mRNA level and NBC protein expression
and, as a consequence, NBC activity wasenhanced.46 Chronic treatment
with blockers of the Ang II signalling, either with ACE inhibitor or with
AT1 receptor antagonists, effectively reduced mRNA
27 and protein
NBC up-regulation and transport activity,46 demonstrating a close
relationship among NBC, Ang II, and myocardial infarction.
Yamamoto et al.27 have demonstrated that NBCe1 and NBCn1 were
overexpressed in ventricular myocytes isolated from hypertrophied rat
hearts subjected to non-ischaemic pressure overload. Although the
authors suggested that the function of both isoforms was also enhanced,
they could not clearly demonstrate the functional up-regulation of
NBCe1 in the hypertrophied hearts.27 Nevertheless, our results show
that, as in Yamamoto’s work, the expression of both isoforms is
increased, but in contrast with their study, the activity of NBCe1 was sig-
nificantly decreased, probably as a consequence of a reduced NBCe1
protein in the cell surface. The disagreement between both investiga-
tions is not clear to us, but should be explained by the different stimulus
that generates the hypertrophy and/or the time that they expended in
this condition. Interestingly, in both studies the changes in the expression
and function of NBC isoforms were prevented using an AT1 receptor
blocker,27 suggesting that this hormone might be involved in the
changes in NBC function and expression during the development of
the maladaptive cardiachypertrophy. In the presentwork, we confirmed
that Ang II is directly involved in NBC isoforms remodelling during
cardiac hypertrophy. However, at the moment we cannot state if the
changes in NBC isoforms expression and activity are a cause or a conse-
quence of cell growth. Nevertheless, the possibility that the remodelling
of the NBC isoforms may not be a cause or a consequence of the path-
ology but simply a different phenotype of a different rat strain cannot be
discarded.
It has been demonstrated that Ang II induces NBCe1 internalization in
Xenopus oocytes.30 Our data demonstrated that in SHR there is a
Figure 5 Impact of NBCe1 current in Wistar and SHR cardiac action potential (AP) configuration. (A) Representative AP recordings performed with
current-clamp in perforated-patch configuration obtained from ventricular myocytes isolated from Wistar and SHR rats, successively exposed to bicar-
bonate solution without a-L3 (control) and bicarbonate solution with a-L3 (a-L3; dilution 1/500). (B) Average values of APD90 of Wistar myocytes in the
absenceandpresenceof a-L3 (n ¼ 5) andof SHRmyocytes in the absence andpresenceof a-L3 (n ¼ 6). *P, 0.05vs. control. (C)Averageof thepercentage
increase of APD90 after exposing the cell to a-L3 in Wistar and SHR rats. Asterisk indicates that the Difference is statistically significant.
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greater amount of NBCe1 protein inside the myocyte in comparison
with the cell surface. The qualitative confocal images suggest that
NBCe1 is retained near the nucleus, probably in the endoplasmic reticu-
lum. This altered NBCe1 distribution correlates with less activity of this
NBC isoform measured with the potassium and ammonium pulses.
Nevertheless, we cannot clearly state whether Ang II decreases sarco-
lemmal stabilization of the protein stimulating its internalization,30 or
there is an inhibition of the recycling of endosomes with NBCe1
during the developmentof cardiac hypertrophy,or there is adisturbance
in the trafficking to the membrane that prevents the arrival of the protein
to the surface. More experiments are needed to clarify this issue.
In the present work, we described for the first time the remodelling of
the NBC isoforms in the hypertrophied hearts of the SHR. These
changes in NBC isoform expression and function described herein
appears to be deleterious rather than compensatory, which allows us
to speculate that these alterations might be indeed involved in the devel-
opment or progression of cardiac hypertrophy. The up-regulation of
NBCn1, which carries more sodium to pull the same amount of bicar-
bonate than the NBCe1, could fairly contribute to [Na+]i and [Ca
2+]i
overload. On the other hand, the prolongation of the cardiac AP
expected after NBCe1 inhibition4,9 might be detrimental due to the
increase in calcium influx through voltage-dependent L-type Ca2+
channel during the plateau. Indeed, the cardiac AP lengthening repre-
sents a hallmark of cardiac hypertrophy47 and it was widely reported
as one of the main causes that lead to this maladaptive growth of the
heart.48 Overall, the results of the present work open a new perspective
regarding the investigation of the NBC isoforms as potential new
therapeutic targets in the treatment of the pressure-overload induced
hypertrophy.
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Supplementary material is available at Cardiovascular Research online.
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